Resistance to Antiplatelet Therapy Is Associated With Symptoms of Cerebral Ischemia in Carotid Artery Disease

BACKGROUND: Platelet inhibitory therapy is prescribed to prevent arterial thromboembolism in patients with atherosclerotic disease. Although taken by millions of people, around 30% are resistant to the treatment they are being prescribed. AIMS: To determine whether symptoms of cerebral ischemia, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Ball, Stephen T. E., Taylor, Rachael, McCollum, Charles N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555613/
https://www.ncbi.nlm.nih.gov/pubmed/32856558
http://dx.doi.org/10.1177/1538574420947235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555613/
https://www.ncbi.nlm.nih.gov/pubmed/32856558
http://dx.doi.org/10.1177/1538574420947235

Ejemplares similares